All research
LL-37 2026-05-29 EuropePMC

Microbial Dysbiosis Drives Photodermatoses Pathogenesis, Revealing Novel Intervention Strategies

Microbial Dysbiosis in Photodermatoses: Formation, Pathogenesis and Intervention Strategies

Background

Photodermatoses are inflammatory skin conditions like polymorphic light eruption (PLE) and chronic actinic dermatitis (CAD), primarily triggered or worsened by ultraviolet radiation (UVR). These conditions, including photoaggravated dermatoses like lupus erythematosus and even actinic keratosis (AK) and cutaneous squamous cell carcinoma (cSCC) due to chronic UVR, significantly impair patient quality of life and psychological health. Current treatments often focus on symptomatic relief or UV avoidance, but a deeper understanding of underlying mechanisms is needed. Recent advances reveal the skin microbiome plays a crucial role in maintaining skin barrier stability and regulating immune responses, suggesting its dysbiosis could contribute to inflammation and disease.

Study Design

This comprehensive review synthesizes current research on the relationship between microbial dysbiosis and various photodermatoses, including polymorphic light eruption (PLE), chronic actinic dermatitis (CAD), actinic prurigo, solar urticaria, lupus erythematosus, actinic keratosis (AK), and cutaneous squamous cell carcinoma (cSCC). The authors integrated findings from numerous studies to elucidate the formation and pathogenic mechanisms of dysbiosis in these conditions. The review also explored potential intervention strategies targeting the skin microbiome, drawing conclusions from existing literature rather than conducting new experimental work.

Results

The review consolidates evidence demonstrating a consistent pattern of dysbiotic microbiome in several photodermatoses. Key findings include a significant decrease in overall microbiome diversity and a notable increase in colonization by pathogenic bacteria, particularly Staphylococcus aureus. This dysbiosis is implicated in promoting inflammation and contributing to the progression of these skin diseases. For instance, PLE affects approximately 18% of the population in Europe, underscoring the widespread impact. The burden on patients is substantial, with around one-third reporting a Dermatology Life Quality Index (DLQI) score greater than 10, indicating a "very large" impact on quality of life. Furthermore, anxiety and depression levels in affected individuals are approximately twice those in the general population.

The review highlights that dysbiosis, characterized by decreased diversity and increased Staphylococcus aureus colonization, is a consistent feature across multiple photodermatoses, directly contributing to inflammation and disease pathogenesis.

The integrated findings suggest that the altered microbial environment disrupts the skin barrier and dysregulates immune responses, creating a pro-inflammatory state exacerbated by UVR exposure.

Key Findings

  • Photodermatoses are linked to decreased skin microbiome diversity.
  • Increased Staphylococcus aureus colonization is a common feature in photodermatoses.
  • Microbial dysbiosis contributes to inflammation and pathogenesis in UVR-induced skin diseases.
  • Photodermatoses significantly impair quality of life, with 18% prevalence for PLE in Europe.

Why It Matters

Understanding the critical role of microbial dysbiosis in photodermatoses opens new avenues for therapeutic intervention beyond traditional UV protection and symptomatic relief. Targeting the skin microbiome could offer a novel strategy to manage these debilitating conditions. This research suggests that future protocols might incorporate microbiome-modulating agents (e.g., prebiotics, postbiotics, or specific bacterial strains) to restore balance, enhance skin barrier function, and dampen inflammation. Developing topical formulations that rebalance the skin microbiome could significantly improve patient outcomes and quality of life for the millions affected by conditions like PLE and CAD. This shift towards a microbiome-centric approach could lead to more effective, mechanism-based treatments, moving beyond broad immunosuppression to precise microbial modulation.


photodermatoses skin-microbiome dysbiosis staphylococcus-aureus inflammation uv-radiation
Source: europepmc:epmc_PMC13204438 · Ingested 2026-05-29 · Digest: gemini-2.5-flash